vs

Side-by-side financial comparison of CABOT CORP (CBT) and Concentra Group Holdings Parent, Inc. (CON). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $539.1M, roughly 1.6× Concentra Group Holdings Parent, Inc.). CABOT CORP runs the higher net margin — 8.6% vs 6.4%, a 2.2% gap on every dollar of revenue. Concentra Group Holdings Parent, Inc. produced more free cash flow last quarter ($98.5M vs $57.0M).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Concentra Inc., is a national health care establishment centered around occupational health. It was founded in 1979 in Amarillo, Texas, and the headquarters of the corporation is in Addison, Texas. It runs 627 occupational health centers and 410 onsite health clinics at employer worksites across 47 states. According to the Bureau of Labor Statistics, Concentra treats one out of every seven occupational injuries in the United States. It is currently a publicly traded company with over 80% of t...

CBT vs CON — Head-to-Head

Bigger by revenue
CBT
CBT
1.6× larger
CBT
$849.0M
$539.1M
CON
Higher net margin
CBT
CBT
2.2% more per $
CBT
8.6%
6.4%
CON
More free cash flow
CON
CON
$41.5M more FCF
CON
$98.5M
$57.0M
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
CON
CON
Revenue
$849.0M
$539.1M
Net Profit
$73.0M
$34.7M
Gross Margin
24.9%
Operating Margin
15.2%
12.9%
Net Margin
8.6%
6.4%
Revenue YoY
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$1.37
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
CON
CON
Q4 25
$849.0M
$539.1M
Q3 25
$899.0M
$572.8M
Q2 25
$923.0M
$550.8M
Q1 25
$936.0M
$500.8M
Q4 24
$955.0M
Q3 24
$1.0B
$489.6M
Q2 24
$1.0B
$477.9M
Q1 24
$1.0B
Net Profit
CBT
CBT
CON
CON
Q4 25
$73.0M
$34.7M
Q3 25
$43.0M
$48.3M
Q2 25
$101.0M
$44.6M
Q1 25
$94.0M
$38.9M
Q4 24
$93.0M
Q3 24
$137.0M
$44.3M
Q2 24
$109.0M
$51.7M
Q1 24
$84.0M
Gross Margin
CBT
CBT
CON
CON
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
CON
CON
Q4 25
15.2%
12.9%
Q3 25
15.2%
16.5%
Q2 25
18.1%
16.3%
Q1 25
17.3%
16.0%
Q4 24
16.2%
Q3 24
15.0%
17.6%
Q2 24
16.9%
17.6%
Q1 24
15.3%
Net Margin
CBT
CBT
CON
CON
Q4 25
8.6%
6.4%
Q3 25
4.8%
8.4%
Q2 25
10.9%
8.1%
Q1 25
10.0%
7.8%
Q4 24
9.7%
Q3 24
13.7%
9.1%
Q2 24
10.7%
10.8%
Q1 24
8.2%
EPS (diluted)
CBT
CBT
CON
CON
Q4 25
$1.37
$0.27
Q3 25
$0.80
$0.38
Q2 25
$1.86
$0.35
Q1 25
$1.69
$0.30
Q4 24
$1.67
Q3 24
$2.41
$0.37
Q2 24
$1.94
$0.50
Q1 24
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
CON
CON
Cash + ST InvestmentsLiquidity on hand
$230.0M
$79.9M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$1.6B
$393.3M
Total Assets
$3.8B
$2.9B
Debt / EquityLower = less leverage
3.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
CON
CON
Q4 25
$230.0M
$79.9M
Q3 25
$258.0M
$49.9M
Q2 25
$239.0M
$73.9M
Q1 25
$213.0M
$52.1M
Q4 24
$183.0M
Q3 24
$223.0M
$136.8M
Q2 24
$197.0M
$50.7M
Q1 24
$206.0M
Total Debt
CBT
CBT
CON
CON
Q4 25
$1.6B
Q3 25
$1.1B
$1.6B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
Q3 24
$1.1B
$1.5B
Q2 24
$3.0M
Q1 24
Stockholders' Equity
CBT
CBT
CON
CON
Q4 25
$1.6B
$393.3M
Q3 25
$1.6B
$385.5M
Q2 25
$1.5B
$342.6M
Q1 25
$1.4B
$307.1M
Q4 24
$1.4B
Q3 24
$1.4B
$277.8M
Q2 24
$1.3B
$1.2B
Q1 24
$1.4B
Total Assets
CBT
CBT
CON
CON
Q4 25
$3.8B
$2.9B
Q3 25
$3.8B
$2.8B
Q2 25
$3.8B
$2.8B
Q1 25
$3.8B
$2.7B
Q4 24
$3.6B
Q3 24
$3.7B
$2.5B
Q2 24
$3.6B
$2.4B
Q1 24
$3.6B
Debt / Equity
CBT
CBT
CON
CON
Q4 25
3.98×
Q3 25
0.70×
4.15×
Q2 25
4.82×
Q1 25
5.27×
Q4 24
Q3 24
0.75×
5.30×
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
CON
CON
Operating Cash FlowLast quarter
$126.0M
$118.7M
Free Cash FlowOCF − Capex
$57.0M
$98.5M
FCF MarginFCF / Revenue
6.7%
18.3%
Capex IntensityCapex / Revenue
8.1%
3.7%
Cash ConversionOCF / Net Profit
1.73×
3.42×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$197.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
CON
CON
Q4 25
$126.0M
$118.7M
Q3 25
$219.0M
$60.6M
Q2 25
$249.0M
$88.4M
Q1 25
$73.0M
$11.7M
Q4 24
$124.0M
Q3 24
$204.0M
$65.9M
Q2 24
$207.0M
Q1 24
$176.0M
Free Cash Flow
CBT
CBT
CON
CON
Q4 25
$57.0M
$98.5M
Q3 25
$155.0M
$39.4M
Q2 25
$188.0M
$63.2M
Q1 25
$1.0M
$-4.0M
Q4 24
$47.0M
Q3 24
$112.0M
$50.8M
Q2 24
$155.0M
Q1 24
$133.0M
FCF Margin
CBT
CBT
CON
CON
Q4 25
6.7%
18.3%
Q3 25
17.2%
6.9%
Q2 25
20.4%
11.5%
Q1 25
0.1%
-0.8%
Q4 24
4.9%
Q3 24
11.2%
10.4%
Q2 24
15.3%
Q1 24
13.1%
Capex Intensity
CBT
CBT
CON
CON
Q4 25
8.1%
3.7%
Q3 25
7.1%
3.7%
Q2 25
6.6%
4.6%
Q1 25
7.7%
3.1%
Q4 24
8.1%
Q3 24
9.2%
3.1%
Q2 24
5.1%
Q1 24
4.2%
Cash Conversion
CBT
CBT
CON
CON
Q4 25
1.73×
3.42×
Q3 25
5.09×
1.26×
Q2 25
2.47×
1.98×
Q1 25
0.78×
0.30×
Q4 24
1.33×
Q3 24
1.49×
1.49×
Q2 24
1.90×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

CON
CON

Occupational Health Center Workers Compensation$328.5M61%
Occupational Health Center Employer Services$151.9M28%
Onsite Health Clinics$36.2M7%
Other Businesses$12.3M2%
Occupational Health Center Consumer Health$8.1M2%
Occupational Health Center Other$2.1M0%

Related Comparisons